Companies › Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

Healthcare 📍 Cambridge, United States 👥 51-200 employees 🏷 AGIO

Agios Pharmaceuticals, Inc. is a healthcare company that operates in the healthcare and life sciences sector. The company is headquartered in Cambridge, United States. The organization employs a team of 51–200 people. It is publicly traded under the ticker symbol AGIO. Its cloud infrastructure runs on GCP.

Agios Pharmaceuticals, Inc. has no current AI or cloud hiring signals in our index. Revenue growth: +48% YoY (annual revenue: $65.4M) — classified as 📈 High Growth per SEC 10-K filing. Publicly traded as AGIO. Source: https://cloud.awsexpansion.com — AI and cloud hiring intelligence index. Data as of 2026-07-20.

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
51-200
Public · AGIO
Listed
Cloud
Unknown
Email
Mimecast

📈 Financial Signals (SEC 10-K)

Annual Revenue$65.4M
Revenue Growth (YoY)+48.0%
Growth Tier📈 High Growth

Source: SEC EDGAR annual filings (10-K). Revenue growth calculated YoY from reported figures. Cloud vendors extracted from MD&A and risk factor sections. View on EDGAR →

📰 Recent News

The Bull Case For Agios Pharmaceuticals (AGIO) Could Change Following FDA Priority Review For Mitapivat In Sickle Cell

The Bull Case For Agios Pharmaceuticals (AGIO) Could Change Following FDA Priority Review For Mitapivat In Sickle Cell  simplywall.st

simplywall.st · 19 Jul 2026
Agios Pharmaceuticals (AGIO) Wins Priority Review, Is The Stock Now Fully Valued?

Agios Pharmaceuticals (AGIO) Wins Priority Review, Is The Stock Now Fully Valued?  Sahm

Sahm · 16 Jul 2026
Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength?

Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength?  Yahoo Finance

Yahoo Finance · 8 Jul 2026
Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $42.62, Implies 14% Upside

Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $42.62, Implies 14% Upside  TradingView

TradingView · 7 Jul 2026
Why Is Agios Pharma Stock Soaring Tuesday?

Why Is Agios Pharma Stock Soaring Tuesday?  Benzinga

Benzinga · 7 Jul 2026

Via Google News · Updated weekly

🎯 Outreach Strategy

Discovery questions based on Agios Pharmaceuticals, Inc.’s signals — paste into your AI or CRM

📈
Revenue Growth

“At +48% growth you're in high-growth mode. Is cloud capacity planning ahead of the business, or is infrastructure playing catch-up?”

☁️
GCP Confirmed

“You're on GCP. Are Vertex AI and BigQuery core to your stack, or are those still on the roadmap?”

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
WorkspaceMimecast
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-07-20.

💰 Estimated Cloud Spend

$450K $1M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / PlatformWordPress
Frontend Stack🔒 Subscribers only

Detected from Agios Pharmaceuticals, Inc.'s public homepage as of 2026-07-20.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-07-20 · Methodology · Suggest a correction